Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) has poor prognosis with limited treatment options, with little therapeutic progress made during the past several decades. DNA damage response (DDR) associated therapies, including radiation and inhibitors of DDR, demonstrate potential efficacy against TNBC, espec...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Curtis A., Yang, Eddy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497895/
https://www.ncbi.nlm.nih.gov/pubmed/34631532
http://dx.doi.org/10.3389/fonc.2021.703802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497895/
https://www.ncbi.nlm.nih.gov/pubmed/34631532
http://dx.doi.org/10.3389/fonc.2021.703802

Ejemplares similares